Activation of human bronchial epithelial cells by inflammatory cytokines IL-27 and TNF-α: Implications for immunopathophysiology of airway inflammation

Journal of Cellular Physiology

Volumn 223, Issue 3, 2010, Pages 788-797

  Cao, Ju ^a   Wong, Chun K ^a   Yin, Yibing ^b   Lam, Christopher W K ^a,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 27; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; PROTEIN KINASE B; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BRONCHUS MUCOSA; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; BRONCHUS; CELL CULTURE; CELL MEMBRANE; DRUG EFFECT; ENZYME ACTIVATION; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SECRETION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BRONCHI; CELL MEMBRANE; CELLS, CULTURED; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-6; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77951223638     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22094     Document Type: Article

References (48)

1. Batten M, Ghilardi N. 2007. The biology and therapeutic potential of interleukin 27. J Mol Med 85:661-672.
2. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681-13686.
3. Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R. 1998. IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Requirement for an additional activation pathway. J Biol Chem 273:6607-6610. (Pubitemid 28160316)
4. Broide D, Sriramarao P. 2001. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev 179:163-172. (Pubitemid 32171283)
5. Carter AB, Knudtson KL, Monick MM, Hunninghake GW. 1999. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem 274:30858-30863. (Pubitemid 129576833)
6. Cheung PF, Wong CK, Lam CW. 2008. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: Implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol 180:5625-5635.
7. Dustin ML, Springer TA. 1998. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 107:321-331.
8. Hamano S, Himeno K, Miyazaki Y, Ishii K, Yamanaka A, Takeda A, Zhang M, Hisaeda H, Mak TW, Yoshimura A, Yoshida H. 2003. WSX-1is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19:657-667.
9. Hammad H, Lambrecht BN. 2008. Dendritic cells and epithelial cells: Linking innate and adaptive immunity in asthma. Nat Rev Immunol 8:193-204. (Pubitemid 351323293)
10. Hölscher C, Hölscher A, Rückerl D, Yoshimoto T, Yoshida H, Mak T, Saris C, Ehlers S. 2005. The IL-27 receptor chain WSX-1differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174:3534-3544. (Pubitemid 40354062)
11. Hunter CA. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5:521-531.
12. Ip WK, Wong CK, Lam CW. 2006. Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: Involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways. Clin Exp Immunol 145:162-172.
13. Ip WK, Wong CK, Li ML, Li PW, Cheung PF, Lam CW. 2007. Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: Implications for the allergic response. Immunology 122:532-541.
14. Kalliolias GD, Ivashkiv LB. 2008. IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J Immunol 180:6325-6333.
15. Kanda N, Watanabe S. 2008. IL-12, IL-23, and IL-27 enhance human beta-defensin-2 production in human keratinocytes. Eur J Immunol 38:1287-1296.
16. Kastelein RA, Hunter CA, Cua DJ. 2007. Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu Rev Immunol 25:221-242.
17. Kato A, Schleimer RP. 2007. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr Opin Immunol l19:711-720. (Pubitemid 350236807)
18. Kawaguchi M, Kokubu F, Kuga H, Matsukura S, Hoshino H, Ieki K, Imai T, Adachi M, Huang SK. 2001. Modulation of bronchial epithelial cells by IL-17. JAllergy Clin Immunol 108:804-809. (Pubitemid 33096214)
19. Khair OA, Davies RJ, Devalia JL. 1996. Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 9:1913-1922.
20. Krunkosky TM, Fischer BM, Martin LD, Jones N, Akley NJ, Adler KB. 2000. Effects of TNFalpha on expression of ICAM-1 in human airway epithelial cells in vitro. Signaling pathways controlling surface and gene expression. Am J Respir Cell Mol Biol 22:685-692. (Pubitemid 30400247)
21. Li XY, Donaldson K, Brown D, MacNee W. 1995. The role of tumor necrosis factor in increased airspace epithelial permeability in acute lung inflammation. Am J Respir Cell Mol Biol 13:185-195.
22. Look DC, Rapp SR, Keller BT, Holtzman MJ. 1992. Selective induction of intercellular adhesion molecule-1 by interferon-gamma in human airway epithelial cells. Am J Physiol 263:L79-L87.
23. Lucas S, Ghilardi N, Li J, de Sauvage FJ. 2003. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci USA 100:15047-15052.
24. Mackay CR. 2008. Moving targets: Cell migration inhibitors as new anti-inflammatory therapies. Nat Immunol 9:988-998.
25. Martin LD, Rochelle LG, Fischer BM, Krunkosky TM, Adler KB. 1997. Airway epithelium as an effector of inflammation: Molecular regulation of secondary mediators. Eur Respir J 10:2139-2146.
26. Mayer AK, Dalpke AH. 2007. Regulation of local immunity by airway epithelial cells. Arch Immunol Ther Exp (Warsz) 55:353-362.
27. Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N, Fujii M. 2002. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 100:1828-1834. (Pubitemid 34925163)
28. Morishima N, Owaki T, Asakawa M, Kamiya S, Mizuguchi J, Yoshimoto T. 2005. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J Immunol 175:1686-1693. (Pubitemid 41023072)
29. Neufert C, Becker C, Wirtz S, Fantini MC, Weigmann B, Galle PR, Neurath MF. 2007. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol 37:1809-1816. (Pubitemid 47065120)
30. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, Blumenschein WM, Mattson JD, Wagner JL, To W, Zurawski S, McClanahan TK, Gorman DM, Bazan JF, de Waal Malefyt R, Rennick D, Kastelein RA. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16:779-790.
31. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, Phillips JH, McClanahan TK, de Waal Malefyt R, Kastelein RA. 2004. WSX-1 and glycoprotein 130 constitute a signaltransducing receptor for IL-27. J Immunol 172:2225-2231.
32. Reisinger J, Triendl A, Küchler E, Bohle B, Krauth MT, Rauter I, Valent P, Koenig F, Valenta R, Niederberger V. 2005. IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammation. J Allergy Clin Immunol 115:973-981.
33. Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC. 2007. Epithelium: At the interface of innate and adaptive immune responses. J Allergy Clin Immunol 120:1279-1284. (Pubitemid 350216601)
34. Stumbles PA, Strickland DH, Pimm CL, Proksch SF, Marsh AM, McWilliam AS, Bosco A, Tobagus I, Thomas JA, Napoli S, Proudfoot AE, Wells TN, Holt PG. 2001. Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: Use of alternative chemokine receptors as a function of inducing stimulus. J Immunol 167:228-234.
35. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'Shea JJ, Hunter CA. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8:1363-1371. (Pubitemid 350131173)
36. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, Yoshimura A, Yoshida H. 2003. Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 170:4886-4890. (Pubitemid 36554716)
37. Trinchieri G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133-146. (Pubitemid 37328691)
38. Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H, Kastelein RA, Saris C, Hunter CA. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19:645-655. (Pubitemid 37490790)
39. Walter MJ, Look DC, Tidwell RM, Roswit WT, Holtzman MJ. 1997. Targeted inhibition of interferon-gamma-dependent intercellular adhesion molecule-1 (ICAM-1) expression using dominant-negative Stat1. J Biol Chem 272:28582-28589.
40. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. 1990. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247:456-459. (Pubitemid 20044636)
41. Welty SE, Rivera JL, Elliston JF, Smith CV, Zeb T, Ballantyne CM, Montgomery CA, Hansen TN. 1993. Increases in lung tissue expression of intercellular adhesion molecule-1 are associated with hyperoxic lung injury and inflammation in mice. Am J Respir Cell Mol Biol 9:393-400.
42. Wirtz S, Tubbe I, Galle PR, Schild HJ, Birkenbach M, Blumberg RS, Neurath MF. 2006. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med 203:1875-1881. (Pubitemid 44188462)
43. Wittmann M, Zeitvogel J, Wang D, Werfel T. 2009. IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. J Allergy Clin Immunol 124:81-89.
44. Wong CK, Wang CB, Li ML, Ip WK, Tian YP, Lam CW. 2006. Induction of adhesion molecules upon the interaction between eosinophils and bronchial epithelial cells: Involvement of p38 MAPK and NF-kappaB. Int Immunopharmacol 6:1859-1871.
45. Wong CK, Cao J, Yin YB, Lam CW. 2010. IL-17A activation on bronchial epithelium and basophils: A novel inflammatory mechanism. Eur Respir J. DOI: 10.1183/09031936. 00088309 [Epub ahead of print].
46. Xu Y, Li S. 2009. Blockade of ICAM-1: A novel way of vasculitis treatment. Biochem Biophys Res Comm 381:459-461.
47. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM, Oppenheim JJ. 1999. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-528.
48. Yoshida H, Yoshiyuki M. 2008. Regulation of immune responses by interleukin-27. Immunol Rev 226:234-247.